ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for Rilparencel

May 2, 2026 - 13:00

ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for Rilparencel

Tags:

Previous Article

Ocugen (OCGN) Completes Enrollment for Phase 2/3 Pivotal Trial of OCU410ST Gene ...

Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Wells Fargo Asserts GE Aerospace (GE) Growth Prospects on Leap SV Ramp

Wells Fargo Asserts GE Aerospace (GE) Growth Prospects ...

Apr 24, 2026

Analyst Report: Gentherm Inc

Analyst Report: Gentherm Inc

Apr 29, 2026

Keurig Dr Pepper Stock: Analyst Estimates & Ratings

Keurig Dr Pepper Stock: Analyst Estimates & Ratings

May 2, 2026